Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Probable Carcinogen Found Haunting More Firms’ Valsartan API
Aug 13 2018
•
By
Bowman Cox
Zhejiang Huahai was not the only API maker visited by unexpected peaks • Source: Wikimedia Commons
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Manufacturing
More from Compliance